Andrew Kim

President and CEO

5 past transactions

Flashback

Convertible Note in 2023
The soul of a film camera reborn in a digital era

Lumotive

Venture Round in 2023
Lumotive LLC specializes in developing advanced solid-state lidar systems utilizing liquid crystal metasurface (LCM) technology, primarily aimed at enhancing sensing and perception capabilities in autonomous vehicles and various other industries. Founded in 2017 and based in Bellevue, Washington, the company produces optical semiconductor solutions, including its proprietary Light Control Metasurface beam steering chips. These chips are designed for seamless integration into consumer electronics, robotics, and industrial automation, offering a compact and efficient means of delivering precise light control. Lumotive's innovative technology aims to simplify lidar systems by reducing their complexity, cost, and size while simultaneously improving performance and reliability, thereby facilitating mass adoption across multiple applications.

Vaxxas

Series C in 2022
Vaxxas is a biotechnology company based in Brisbane, Australia, focused on developing a novel needle-free vaccination technology. Established in 2011, Vaxxas employs proprietary dry-coating technology that significantly reduces or eliminates the need for refrigeration during the storage and transportation of vaccines, thereby addressing logistical challenges associated with the cold chain. The company's innovative delivery system features an array of vaccine-coated micro projections that penetrate the outer layers of the skin when applied with a specialized applicator device. This method allows for the direct deposition of vaccines among a dense population of immune cells in the skin, potentially transforming the global delivery of vaccines.

LifeSignals Group

Series C in 2016
LifeSignals Group Inc. develops semiconductor-based biosensors and software for medical device manufacturers, focusing on wireless health sensing and remote patient monitoring wearables. The company provides hardware and software solutions, including the Life Signal Patch, Life Signal Receiver, and a development toolkit with an SDK and reference designs such as Life Signal CardiacApp to receive, analyze, and display patient data. Its platform accommodates multiple sensor interfaces and radios, enabling reliable operation in noisy wireless environments and supporting rapid concept-to-market for clinical-grade remote monitoring solutions. Headquartered in Fremont, California, LifeSignals aims to deliver cost-effective biometric monitoring by integrating sensing, wireless communication, and cloud-enabled software for healthcare devices.

Funetics

Seed Round in 2014
Funetics is a digital English-pronunciation platform based in Paddington, Australia, launched in July 2013. The company specializes in providing an English e-learning platform that focuses on teaching users proper pronunciation and fluency in the English language. Utilizing machine learning, Funetics analyzes the spoken language of its users to offer personalized recommendations and content tailored to individual learning profiles. This innovative approach enables users to improve their pronunciation skills and achieve fluency in English effectively.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.